Pharmaceutical composition containing combination of vitamin K1 and K2 and its application

• 1. 一种含有碳酸钙、维生素D3、维生素K2的药物组合物 [P] . 中国专利： CN108478595B . 2021.07.02
• 2. 一种含有碳酸钙、维生素D3、维生素K2的药物组合物 [P] . 中国专利： CN108478595A . 2018-09-04
• 3. Pharmaceutical composition containing combination of vitamin K1, K2 and D3 and its application [P] . PL414903A1 . 2017-06-05

  机译： 含有维生素K1，K2和D3的组合的药物组合物及其应用

• 4. Pharmaceutical composition containing combination of vitamin K1 and D3 and its application [P] . PL414906A1 . 2017-06-05

  机译： 含有维生素K1和D3的组合的药物组合物及其应用

• 5. Pharmaceutical composition containing combination of vitamin D3 and K2 and its application [P] . PL413857A1 . 2017-03-13

  机译： 含有维生素D3和K2的组合的药物组合物及其应用

• 1. Preclinical Evaluation of Pharmaceutical Compositions and Their Components for Urinary Health [J] . Francesco De Seta, Jonathan Wayne Lowery, Oladipupo Ogunbekun OMS II, 妇产科期刊（英文） . 2020,第001期
• 2. Screening Research of Pharmaceutical Compositions Based on Succinic Acid, Ascorbic Acid and Rutin [J] . Mariya Leleka, Olha Zalis＇ka, Galyna Kozyr 药剂与药理学：英文版 . 2016,第009期
• 3. Menadione (Vitamin K3) Is a Catabolic Product of Oral Phylloquinone (Vitamin K1) in the Intestine and a Circulating Precursor of Tissue Menaquinone-4 (Vitamin K2) in Rats [J] . Yoshihisa Hirota, Naoko Tsugawa, Kimie Nakagawa, The Journal of biological chemistry . 2013,第46期
• 4. Vitamin K1 and Vitamin K2 immunopharmacological effects on the peripheral lymphocytes of healthy subjects and dialysis patients, as estimated by the lymphocyte immunosuppressant sensitivity test [J] . Kusano Junichi, Tanaka Sachiko, Matsuda Hiroto, Journal of Clinical Pharmacy and Therapeutics . 2018,第6期
• 5. The effects of vitamin K1 and vitamin K2 on the proliferation, cytokine production and regulatory T-cell frequency in peripheral blood mononuclear cells of paediatric atopic dermatitis patients [J] . Meng Kehan, Xu Wencheng, Miura Taro, Experimental dermatology . 2018,第9期
• 6. Rectangular TeraHertz Microstrip Patch Antenna design for Vitamin K2 detection applications [C] . Prince, Gurleen Kaur, Vishal Mehta, International Conference on Electronics, Materials Engineering and Nano-Technology . 2017
• 7. The application of first principle modeling in combination with empirical design of experiments and real-time data management for the automated control of pharmaceutical operations. [D] . Zacour, Brian M. 2012
• 8. Menadione (Vitamin K3) Is a Catabolic Product of Oral Phylloquinone (Vitamin K1) in the Intestine and a Circulating Precursor of Tissue Menaquinone-4 (Vitamin K2) in Rats [O] . Yoshihisa Hirota, Naoko Tsugawa, Kimie Nakagawa, 2013
• 9. Updating of the Irish Food Composition Database for vitamin K1 and vitamin K2 [O] . C. Kingston, L. Kehoe, B.A. McNulty, 2020
• 10. Resource Conservation and Recovery Act: Part B, Permit application. Volume 5, Appendices E1, H1, I1--3, K1, K2, L1. [R] . 1991

• 1. Euler方程φ(xy)=k1φ(x)+k2φ(y)(k1≠k2)的正整数解 [J] . 张四保 ,官春梅 ,席小忠 . 郑州大学学报（理学版） . 2017,第001期
• 2. Assessment of Gross Chemical Composition, Mineral Composition, Vitamin Composition and Amino Acids Composition of Wheat Biscuits and Wheat Germ Fortified Biscuits [J] . Hanan M. K. E. Youssef . 食品与营养科学（英文） . 2015,第10期
• 3. Therapeutic Efficacy of Genistein-Topotecan Combination Compared to Vitamin D3-Topotecan Combination in LNCaP Prostate Cancer Cells [J] . Shreyasee Chakraborty ,Bibiana Sandoval-Bernal ,James Kumi-Diaka . 细胞生物学（英文） . 2013,第3期
• 4. 可生物降解聚合物纳米胶囊型药物载体及组合胶囊的药物控制释放 [C] . 董岸杰 ,邓联东 . 2005年中德纳米生物技术国际会议 . 2005
• 5. 以改性分子筛和含有药物成分的缔合物作为选择性电极载体的应用研究 [A] . 张双艳 . 2017